Formulation and Drug Delivery, Combination Drugs

December 13th 2023

A look at how linker technology for antibody drug conjugates has evolved.

November 6th 2023

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, talks about the differences in designing E&L testing for combination products vs. conventional pharmaceuticals.

November 3rd 2023

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.

November 29th 2022

The decision to move forward in Phase III development stems from the threat of resistance to current malaria treatment growth.